Mainstream medicine is ruining a revitalizing therapy that can help millions of men

There are millions of men who could benefit from one particularly controversial therapy, but are avoiding treatment based on unfounded mainstream myths.

So today, I want to take a little time to separate fact from fiction and clue you in on what you really need to know.

I’m talking about testosterone replacement therapy (TRT).

Unlike what you may have heard, testosterone therapy doesn’t cause prostate cancer, nor does it increase your risk for this cancer. Period.

What’s more, men stand to gain considerable health benefits from TRT, as long as they follow a few simple ground rules, which I’ll touch on in just a moment.

Providing benefits beyond prostate health

As men age, their testosterone levels drop…and drop, and drop. And with each drop-off, their health and overall well-being takes a hit.

But as the latest research clearly shows, men who take steps to raise their testosterone end up feeling more energetic. They also reduce their risk of heart disease, heart attack, and stroke.

And those benefits just scrape the surface…

In a recent urology study from Boston University School of Medicine, researchers compared a group of 360 men in their 50s and 60s who used TRT for a long duration of time (up to 10 years in some) to a similar group of about 300 men who hadn’t undergone treatment.

Researchers collected data on the men, including whether or not they experienced the following urinary symptoms:

  • A noticeably weak urinary stream
  • Frequent urination
  • Incomplete bladder emptying
  • Waking at night to urinate

The analysis showed that men treated with TRT had fewer urinary symptoms overall.

In addition, the TRT group had higher scores on assessments of erectile/sexual health and general quality of life.

These are good indications that TRT has a positive effect on the prostate.

But what about its effect on prostate cancer and prostate cancer treatments?

Many men are understandably concerned about a particular prostate cancer treatment called androgen deprivation — which employs surgery or drugs to stop the body’s production of testosterone. And since this reduction of testosterone is effective in fighting some forms of prostate cancer, healthy men who have no prostate cancer wonder if following the opposite course of action — increasing testosterone — might also increase their risk of the disease.

Fortunately, as we now know, that’s not the case.

TRT is a prostate cancer preventative

In Dr. Fred Pescatore’s Essential Protocol to a Cancer-Free Future, he says he understands the doubts some of his male patients have about TRT, but he’s able to assure them that the therapy doesn’t put them at risk.

In fact, just the opposite. He cites a recent study in which TRT was actually protective against prostate cancer.

Researchers at New York University analyzed medical records of more than 250,000 Swedish men. Results showed no increase in prostate cancer risk among those who used TRT for more than a year.

And remarkably, the risk of aggressive forms of the disease — the kind, Dr. Pescatore notes, “that can actually kill you” — was a stunning 50 percent lower with long-term TRT.

“It seems to me,” Dr. Pescatore says, “that not treating low T is by far the riskier approach.”

Work only with a doctor in-the-know 

Dr. Pescatore believes that any man who’s reached middle-aged and is feeling tired, unmotivated, or uninterested in sex should have his testosterone levels checked.

He notes that optimal testosterone levels vary with age, and offers this general decade-by-decade guideline for ideal levels:

  • 1,200 ng/dl at age 30
  • 1,000 ng/dl at 40
  • 800 ng/dl at 50
  • 700 ng/dl at 60
  • 600 ng/dl at 70, and so on

Dr. Pescatore says he generally starts with 100 mg/gram dosages of bioidentical compounded testosterone almost exclusively.

And he offers this tip: “All testosterone is bioidentical. It’s just the delivery system that makes up the ‘patentable’ part of the formulation. The difference ultimately boils down to price. If your insurance doesn’t cover testosterone replacement therapy, bioidentical compounded products will be significantly cheaper than commercial brands.”

And although TRT is safe, Dr. Pescatore notes that TRT should always be “individualized.” In other words, one size doesn’t fit all. And he adds, “Since your dosage will depend on your baseline numbers and other clinical factors, you should definitely work with a doctor who knows what they’re doing.”

For assistance in locating a provider near you, refer to the Resource Directory included with Dr. Pescatore’s Essential Protocol to a Cancer-Free Future. In this comprehensive online learning tool, you’ll also find a wealth of drug-free strategies to prevent, treat, and even reverse a wide range of common cancers — including prostate cancer. Click here to learn more about Dr. Pescatore’s proactive approaches to preventing and treating cancer, or to enroll today.

SOURCES

“Long-Term Testosterone Therapy Improves Urinary and Sexual Function, and Quality of Life in Men with Hypogonadism: Results from a Propensity Matched Subgroup of a Controlled Registry Study.” Journal of Urology 2018; 199(1): 257-265. doi.org/10.1016/j.juro.2017.07.039